Resources Management Corp CT ADV Lowers Holdings in Danaher Co. (NYSE:DHR)

Resources Management Corp CT ADV lowered its holdings in Danaher Co. (NYSE:DHR) by 0.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,454 shares of the conglomerate’s stock after selling 149 shares during the quarter. Danaher accounts for 1.7% of Resources Management Corp CT ADV’s holdings, making the stock its 15th largest holding. Resources Management Corp CT ADV’s holdings in Danaher were worth $12,637,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Adalta Capital Management LLC raised its holdings in Danaher by 52.3% in the 3rd quarter. Adalta Capital Management LLC now owns 8,467 shares of the conglomerate’s stock valued at $2,356,000 after buying an additional 2,907 shares during the period. LRI Investments LLC increased its position in shares of Danaher by 82.5% during the third quarter. LRI Investments LLC now owns 4,545 shares of the conglomerate’s stock valued at $1,264,000 after acquiring an additional 2,055 shares during the last quarter. Gordian Capital Singapore Pte Ltd raised its stake in shares of Danaher by 26.1% in the 3rd quarter. Gordian Capital Singapore Pte Ltd now owns 1,400 shares of the conglomerate’s stock valued at $389,000 after acquiring an additional 290 shares during the period. PYA Waltman Capital LLC lifted its holdings in shares of Danaher by 3.0% in the 3rd quarter. PYA Waltman Capital LLC now owns 33,368 shares of the conglomerate’s stock worth $9,277,000 after acquiring an additional 970 shares during the last quarter. Finally, Geller Advisors LLC lifted its holdings in shares of Danaher by 3.7% in the 3rd quarter. Geller Advisors LLC now owns 1,859 shares of the conglomerate’s stock worth $517,000 after acquiring an additional 67 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Up 2.5 %

NYSE:DHR opened at $235.91 on Tuesday. Danaher Co. has a 1 year low of $217.96 and a 1 year high of $281.70. The stock has a market cap of $170.39 billion, a P/E ratio of 45.02, a P/E/G ratio of 4.23 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a 50-day simple moving average of $249.91 and a 200-day simple moving average of $258.14.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the company posted $2.02 earnings per share. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. As a group, analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on DHR shares. Stifel Nicolaus boosted their target price on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a report on Thursday, December 5th. Robert W. Baird lowered their target price on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. KeyCorp lifted their target price on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Finally, Royal Bank of Canada reduced their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.